Dudley Robert Michael 13D/13G Filings for TransCode Therapeutics, Inc. (RNAZ)

Dudley Robert Michael 13D and 13G filings for TransCode Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-12-19
5:36 pm
Unchanged
2022-10-0113DTRANSCODE THERAPEUTICS INC
RNAZ
Dudley Robert Michael2
12.700%
0
(Unchanged)
Filing
2022-12-19
5:32 pm
Purchase
2021-12-3113GTRANSCODE THERAPEUTICS INC
RNAZ
Dudley Robert Michael2
10.600%
2increase
(New Position)
Filing